The expression of thioredoxin-1 in preterm delivery placenta

Redox Report

Volumn 17, Issue 5, 2012, Pages 187-193

  Song, Junying ^a,e   Dong, Xudong ^a,b   Chen, Yan ^a   Chen, Guixian ^b   Liang, Hong ^b   Nakamura, Hajime ^c   Yodoi, Junji ^d   Bai, Jie ^a  

^a KUNMING UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b FIRST PEOPLE S HOSPITAL OF YUNNAN PROVINCE   (China)

^c Kitano Hospital   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e HENAN UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Inflammation; Oxidative stress; Preterm delivery; Term delivery; Thioredoxin 1

Indexed keywords

CYCLOOXYGENASE 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; THIOREDOXIN 1; TRANSCRIPTION FACTOR FKHRL1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; PLACENTA; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADULT; CYCLOOXYGENASE 2; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; PLACENTA; PREGNANCY; PREMATURE BIRTH; THIOREDOXINS; YOUNG ADULT;

EID: 84867663894     PISSN: 13510002     EISSN: 17432928     Source Type: Journal    
DOI: 10.1179/1351000212Y.0000000021     Document Type: Article

References (55)

1. Menon R. Spontaneous preterm birth, a clinical dilemma: etiologic, pathophysiologic and genetic heterogeneities and racial disparity. Acta Obstet Gynecol Scand 2008;87(6):590-600.
2. Creasy RK. Preventing preterm birth. N Engl J Med 1991; 325(10):727-9.
3. Medina TM, Hill DA. Preterm premature rupture of membranes: diagnosis and management. Am Fam Physician 2006; 73(4):659-64.
4. Sakata M, Sado T, Kitanaka T, Naruse K, Noguchi T, Yoshida S, et al. Iron-dependent oxidative stress as a pathogenesis for preterm birth. Obstet Gynecol Surv 2008;63(10):651-60.
5. Myatt L, Cui XL. Oxidative stress in the placenta. Histochem Cell Biol 2004;122(4):369-82.
6. Romero R, Oyarzun E, Mazor M, Sirtori M, Hobbins JC, Bracken M. Meta-analysis of the relationship between asymptomatic bacteriuria and preterm delivery/low birth weight. Obstet Gynecol 1989;73(4):576-82.
7. LeBlanc MM, Giguere S, Lester GD, Brauer K, Paccamonti DL. Relationship between infection, inflammation and premature parturition in mares with experimentally induced placentitis. Equine Vet J 2012;44 Suppl:418-14.
8. Challis JR, Lockwood CJ, Myatt L, Norman JE, Strauss JF, Petraglia F. Inflammation and Pregnancy. Reprod Sci 2009; 16(2):206-15.
9. Mocatta TJ, Winterbourn CC, Inder TE, Darlow BA. The effect of gestational age and labour on markers of lipid and protein oxidation in cord plasma. Free Radic Res 2004;38(2):185-91.
10. Qanungo S, Mukherjea M. Ontogenic profile of some antioxidants and lipid peroxidation in human placental and fetal tissues. Mol Cell Biochem 2000;215(1-2):11-9.
11. Burton GJ, Jauniaux E. Oxidative stress. Best Pract Res Clin Obstet Gynaecol 2011;25(3):287-99.
12. Sahlin L, Ostlund E, Wang H, Holmgren A, Fried G. Decreased expression of thioredoxin and glutaredoxin in placentae from pregnancies with pre-eclampsia and intrauterine growth restriction. Placenta 2000;21(7):603-9.
13. Clifton VL, Vanderlelie J, Perkins AV. Increased anti-oxidant enzyme activity and biological oxidation in placentae of pregnancies complicated by maternal asthma. Placenta 2005;26(10): 773-9.
14. Vanderlelie J, Venardos K, Clifton VL, Gude NM, Clarke FM, Perkins AV. Increased biological oxidation and reduced antioxidant enzyme activity in pre-eclamptic placentae. Placenta 2005;26(1):53-8.
15. Holmgren A. Redox regulation by thioredoxin and thioredoxin reductase. Biofactors 2000;11(1-2):63-4.
16. Clarke FM, Orozco C, Perkins AV, Cock I, Tonissen KF, Robins AJ, et al. Identification of molecules involved in the 'early pregnancy factor' phenomenon. J Reprod Fertil 1991;93(2):525-39.
17. Matsui M, Oshima M, Oshima H, Takaku K, Maruyama T, Yodoi J, et al. Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene. Dev Biol 1996;178(1): 179-85.
18. Ejima K, Koji T, Nanri H, Kashimura M, Ikeda M. Expression of thioredoxin and thioredoxin reductase in placentae of pregnant mice exposed to lipopolysaccharide. Placenta 1999;20(7): 561-6.
19. Shibata E, Ejima K, Nanri H, Toki N, Koyama C, Ikeda M, et al. Enhanced protein levels of protein thiol/disulphide oxidoreductases in placentae from pre-eclamptic subjects. Placenta 2001;22(6):566-72.
20. Patwari P, Higgins LJ, Chutkow WA, Yoshioka J, Lee RT. The interaction of thioredoxin with Txnip. Evidence for formation of a mixed disulfide by disulfide exchange. J Biol Chem 2006; 281(31):21884-91.
21. Junn E, Han SH, Im JY, Yang Y, Cho EW, Um HD, et al., Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. J Immunol 2000; 164(12):6287-95.
22. Arias F, Victoria A, Cho K, Kraus F. Placental histology and clinical characteristics of patients with preterm premature rupture of membranes. Obstet Gynecol 1997;89(2):265-71.
23. Vince G, Shorter S, Starkey P, Humphreys J, Clover L, Wilkins T, et al. Localization of tumour necrosis factor production in cells at the materno/fetal interface in human pregnancy. Clin Exp Immunol 1992;88(1):174-80.
24. Hunt JS, Chen HL, Hu XL, Tabibzadeh S. Tumor necrosis factor-alpha messenger ribonucleic acid and protein in human endometrium. Biol Reprod 1992;47(1):141-7.
25. Roos KL, Simmons DL. Cyclooxygenase variants: the role of alternative splicing. Biochem Biophys Res Commun 2005; 338(1):62-9.
26. Shoji T, Yoshida S, Mitsunari M, Miyake N, Tsukihara S, Iwabe T, et al. Involvement of p38 MAP kinase in lipopolysaccharideinduced production of pro-and anti-inflammatory cytokines and prostaglandin E(2) in human choriodecidua. J Reprod Immunol 2007;75(2):82-90.
27. Zhu XO, Yang Z, Guo CM, Ni XT, Li JN, Ge YC, et al. Paradoxical stimulation of cyclooxygenase-2 expression by glucocorticoids via a cyclic AMP response element in human amnion fibroblasts. Mol Endocrinol 2009;23(11):1839-49.
28. Li J, Du W, Maynard S, Andreassen PR, Pang Q. Oxidative stress-specific interaction between FANCD2 and FOXO3a. Blood 2010;115(8):1545-8.
29. Dollner H, Vatten L, Halgunset J, Rahimipoor S, Austgulen R. Histologic chorioamnionitis and umbilical serum levels of proinflammatory cytokines and cytokine inhibitors. BJOG 2002; 109(5):534-9.
30. Almasry SM, Eldomiaty MA, Elfayomy AK, Habib FA. Expression pattern of tumor necrosis factor alpha in placentae of idiopathic fetal growth restriction. J Mol Histol 2012;DOI 10.1007/s10735-012-9410-6.
31. Kniss DA. Cyclooxygenases in reproductive medicine and biology. J Soc Gynecol Investig 1999;6(6):285-92.
32. Roos KL, Simmons DL, Cyclooxygenase variants: the role of alternative splicing. Biochem Biophys Res Commun 2005; 338(1):62-9.
33. Goldenberg RL, Hauth JC, AndrewsWW. Intrauterine infection and preterm delivery. N Engl J Med 2000;342(20):1500-7.
34. Burdon C, Mann C, Cindrova-Davies T, Ferguson-Smith AC, Burton GJ. Oxidative stress and the induction of cyclooxygenase enzymes and apoptosis in the murine placenta. Placenta 2007; 28(7):724-33.
35. Yodoi J, Nakamura H, Masutani H. Redox regulation of stress signals: possible roles of dendritic stellate TRX producer cells (DST cell types). Biol Chem 2002;383(3-4):585-90.
36. Mougiakakos D, Johansson CC, Jitschin R, Bottcher M, Kiessling R. Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress. Blood 2011;117(3):857-61.
37. Padmini E, Lavanya S. HSP70-mediated control of endothelial cell apoptosis during pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 2011;156(2):158-64.
38. Ejima K, Nanri H, Toki N, Kashimura M, Ikeda M. Localization of thioredoxin reductase and thioredoxin in normal human placenta and their protective effect against oxidative stress. Placenta 1999;20(1):95-101.
39. Ejima K, Nanri H, Araki M, Koji T, Shibata E, Kashimura M, et al. Expression of mitochondrial thioredoxin-dependent antioxidant protein, SP-22, in normal human and inflammatory mouse placentae. Placenta 2000;21(8):847-52.
40. Nishiyama A, Masutani H, Nakamura H, Nishinaka Y, Yodoi J. Redox regulation by thioredoxin and thioredoxin-binding proteins. IUBMB Life 2001;52(1-2):29-33.
41. Bai J, Nakamura H, Kwon YW, Hattori I, Yamaguchi Y, Kim YC, et al. Critical roles of thioredoxin in nerve growth factormediated signal transduction and neurite outgrowth in PC12 cells. J Neurosci 2003;23(2):503-9.
42. Li XN, Song J, Zhang L, LeMaire SA, Hou X, Zhang C, et al. Activation of the AMPK-FOXO3 pathway reduces fatty acidinduced increase in intracellular reactive oxygen species by upregulating thioredoxin. Diabetes 2009;58(10):2246-57.
43. Castrillon DH, Miao L, Kollipara R, Horner JW, DePinho RA. Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science 2003;301(5630):215-8.
44. Hosaka T, Biggs WH III, Tieu D, Boyer AD, Varki NM, Cavenee WK, et al., Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc Natl Acad Sci USA 2004; 101(9):2975-80.
45. Kops GJ, Dansen TB, Polderman PE, Saarloos I, Wirtz KW, Coffer PJ, et al. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 2002;419(6904): 316-21.
46. Nemoto S, Finkel T. Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 2002; 295(5564):2450-2.
47. Lappas M, Lim R, Riley C, Menon R, Permezel M. Expression and localisation of FoxO3 and FoxO4 in human placenta and fetal membranes. Placenta 2010;31(12):1043-50.
48. Pringle KG, Kind KL, Sferruzzi-Perri AN, Thompson JG, Roberts CT. Beyond oxygen: complex regulation and activity of hypoxia inducible factors in pregnancy. Hum Reprod Update 2010;16(4):415-31.
49. Rajakumar A, Conrad KP. Expression, ontogeny, and regulation of hypoxia-inducible transcription factors in the human placenta. Biol Reprod 2000;63(2):559-69.
50. Semenza GL. HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol 2001;13(2):167-71.
51. Welsh J, Wietzke JA, Zinser GM, Smyczek S, Romu S, Tribble E, et al. Impact of the Vitamin D3 receptor on growth-regulatory pathways in mammary gland and breast cancer. J Steroid Biochem Mol Biol 2002;83(1-5):85-92.
52. Kim YH, Coon A, Baker AF, Powis G. Antitumor agent PX-12 inhibits HIF-1alpha protein levels through an Nrf2/PMF-1-mediated increase in spermidine/spermine acetyl transferase. Cancer Chemother Pharmacol 2011;68(2):405-13.
53. Jung YJ, Isaacs JS, Lee S, Trepel J, Neckers L. IL-1betamediated up-regulation of HIF-1alpha via an NFkappaB/ COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J 2003;17(14):2115-7.
54. Jung Y, Isaacs JS, Lee S, Trepel J, Liu ZG, Neckers L. Hypoxiainducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappa B activation. Biochem J 2003;370(Pt 3):1011-7.
55. Scortegagna M, Cataisson C, Martin RJ, Hicklin DJ, Schreiber RD, Yuspa SH, et al. HIF-1alpha regulates epithelial inflammation by cell autonomous NFkappaB activation and paracrine stromal remodeling. Blood 2008;111(7):3343-54.